Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Research (NRC) Cash & Equivalents (2016 - 2025)

National Research (NRC) has disclosed Cash & Equivalents for 16 consecutive years, with $4.1 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents fell 1.45% to $4.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.1 million through Dec 2025, down 1.45% year-over-year, with the annual reading at $4.1 million for FY2025, 1.45% down from the prior year.
  • Cash & Equivalents hit $4.1 million in Q4 2025 for National Research, up from $2.2 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $54.4 million in Q4 2021 to a low of $485000.0 in Q2 2024.
  • Historically, Cash & Equivalents has averaged $20.7 million across 5 years, with a median of $14.5 million in 2023.
  • Biggest five-year swings in Cash & Equivalents: crashed 97.84% in 2024 and later surged 987.42% in 2025.
  • Year by year, Cash & Equivalents stood at $54.4 million in 2021, then tumbled by 53.96% to $25.0 million in 2022, then crashed by 74.03% to $6.5 million in 2023, then plummeted by 35.38% to $4.2 million in 2024, then dropped by 1.45% to $4.1 million in 2025.
  • Business Quant data shows Cash & Equivalents for NRC at $4.1 million in Q4 2025, $2.2 million in Q3 2025, and $5.3 million in Q2 2025.